Sales Channels and Strategies - The company has two main sales channels: hospital clinical sales for high-value consumables and home medical devices sold through pharmacies and e-commerce [1] - E-commerce has rapidly developed over the past two years, becoming a significant growth point for the company's external sales channels [1] - The company has strengthened control over terminal sales, including personnel deployment, sales expenses, and brand promotion [1] E-commerce Impact - The impact of online product sales prices on offline prices is minimal due to strict product differentiation and price control across various platforms [2] - New models are specifically designed for online sales, avoiding price conflicts with offline products [2] Medical Cloud Development - The medical cloud platform, launched in May, has seen significant growth, with user numbers increasing geometrically after the introduction of excellent physicians [2] - The focus is on user tracking and maintenance to ensure high-quality service, with plans to expand chronic disease management services [2] Acquisition and Operational Efficiency - Following the acquisition of Shanghai Medical Device Group, there have been no major changes to the management team [3] - Future efforts will focus on cost reduction, employee incentives, and product structure enhancement to improve overall competitiveness [3] New Product Development - The company is cautious about promoting new products, including the recently launched sleep apnea machine, which utilizes leading international technology [3] - The product is expected to grow alongside the market, targeting both personal and medical fields [3] Non-Public Offering Progress - The company's non-public offering application was submitted in August and has been accepted by the China Securities Regulatory Commission, with no recent updates available [3]
鱼跃医疗(002223) - 2015年11月18日投资者关系活动记录表